Peritoneal Mesothelioma

If you or a loved one has been diagnosed with peritoneal mesothelioma, you may have a valid claim — and you may not be aware of the full range of compensation available to your family. The abdominal form is the less familiar one, and we can explain what it changes and what it doesn't before you decide anything.

The peritoneum is the membrane that lines the abdominal cavity and wraps the organs inside it. Like the pleura in the chest, it is a mesothelial membrane — the same tissue type, in a different body cavity — with a small amount of fluid allowing the organs to move against one another.

Mesothelioma arising in that membrane is peritoneal mesothelioma. The published literature places it at roughly 10% to 20% of malignant mesotheliomas, making it the second most common site after the pleura.

However, its behavior differs from the pleural form in a way that shapes treatment. It tends to spread across the surfaces of the abdominal cavity — over the peritoneum, the omentum, and the surfaces of organs — and it seldom metastasizes early through the bloodstream. That pattern of surface-confined disease is what makes an aggressive surgical approach viable for some patients in a way it generally is not for pleural disease.

A reasonable question is how inhaled fibers cause a cancer in the abdomen.

Two routes are generally described. Fibers may be swallowed as well as inhaled — cleared from the airways by the mucociliary escalator and then swallowed, or ingested directly from contaminated hands, food, or drink in a dusty workplace — and pass into the digestive tract and through the bowel wall. Alternatively, fibers deposited in the lung may migrate through the diaphragm and the lymphatic system into the abdominal cavity.

What matters practically is that the exposure history is the same. Peritoneal mesothelioma arises from asbestos exposure in the same occupational and household settings as the pleural form, and the CDC's description of latency between first exposure and clinical disease as usually 20 to 40 years applies here too.

Keep in mind that there is no separate category of "peritoneal jobs." The reconstruction of an exposure history proceeds exactly as it does for pleural disease, across the settings covered in the exposure and occupation cluster.

Peritoneal mesothelioma is harder to catch early than the pleural form, and its symptoms are the reason.

Abdominal swelling or distension, often from ascites — fluid accumulating in the abdominal cavity. Abdominal or pelvic pain. Bloating and a feeling of fullness. Changes in bowel habit. Nausea. Unintentional weight loss, sometimes alongside an increasing waistline, which is a confusing combination. Fatigue. Occasionally a palpable mass or a new hernia.

Every one of those is shared with far more common conditions — irritable bowel syndrome, ovarian pathology, liver disease, hernia, ordinary digestive complaints. People are frequently investigated and treated for those first, sometimes for months.

In fact, a meaningful number of cases are found incidentally, during surgery undertaken for a suspected hernia, a gynecological problem, or unexplained ascites, when the surgeon encounters unexpected disease on the peritoneal surfaces.

As with the pleural form, the most useful thing you can do is tell every clinician about your asbestos history explicitly. It changes the differential.

Diagnosis follows the same sequence as the pleural form, with the imaging aimed at the abdomen and one additional step that drives treatment selection.

Imaging. CT of the abdomen and pelvis is usually first, showing ascites, peritoneal thickening, omental disease, or masses. MRI and PET-CT contribute to assessing extent.

Fluid sampling. Ascitic fluid may be drawn and examined, but as with pleural fluid, cytology alone is frequently insufficient to establish the diagnosis.

Tissue biopsy. Confirmation generally requires tissue, obtained by image-guided biopsy or, commonly, by laparoscopy — which has the additional advantage of allowing direct assessment of how widely disease is distributed.

Pathology and immunohistochemistry. A stain panel distinguishes mesothelioma from other abdominal malignancies and establishes the subtype, with epithelioid generally carrying the more favorable outlook.

Extent of disease. Because treatment selection depends heavily on how much of the abdomen is involved, assessment of disease distribution is a central part of the workup, and a scoring of that extent is typically recorded.

The complete pathology report is the anchor document for both treatment and any claim, and the date of diagnosis frequently starts the legal clock — see statute of limitations in asbestos cases.

This is where peritoneal mesothelioma diverges most from the pleural form, and it's the reason a specialist referral matters so much.

Because the disease tends to remain distributed over abdominal surfaces rather than spreading early through the bloodstream, a combined approach becomes possible for selected patients: cytoreductive surgery, which removes visible disease from the peritoneal surfaces, followed by hyperthermic intraperitoneal chemotherapy — heated chemotherapy circulated directly within the abdominal cavity at the time of surgery.

The published outcomes represent a meaningful change from historical expectations, though they vary considerably between series and between patient groups. Reported figures include median overall survival of 36 months with 1-, 3-, and 5-year survival of 69%, 43%, and 29% in one series, and 53 months with 1-, 3-, and 5-year survival of 76%, 55%, and 49% in another. One review describes a disease previously uniformly fatal now showing 5-year survival of 50% to 60% following CRS-HIPEC in patients with epithelioid histology and limited disease burden.

Keep in mind that those figures require careful reading. They describe selected patients — favorable histology, limited disease extent, fitness to undergo major surgery — treated at high-volume specialist centers. Factors reported as independently associated with better outcome include age under 60, complete or near-complete resection, and low histologic grade. They are not a prediction for any individual, and many patients are not candidates.

Overall, treatment for this disease is concentrated in a small number of specialist centers, and whether someone is a candidate is a decision for that kind of team. That is a medical question entirely, and nothing here substitutes for it.

Legally, peritoneal mesothelioma is not a different kind of case. It is an asbestos disease, proved with a pathology report and an exposure history, against the manufacturers of the products that caused the exposure.

Three practical differences are worth noting.

The diagnostic delay can be longer, because abdominal symptoms are attributed to common conditions and the disease is sometimes found incidentally at surgery. That history of earlier visits and alternative diagnoses is worth collecting, because it forms part of the timeline.

The treatment burden is different. Cytoreductive surgery with HIPEC is major surgery with a long recovery, and where it is undertaken it is a substantial part of the consequences of the disease.

The exposure investigation is identical. There is no distinct occupational profile for peritoneal disease, so the reconstruction proceeds from Social Security earnings records, union records, military service records, and co-worker testimony exactly as it does for pleural disease. Household exposure is equally relevant — see take-home and secondary exposure.

Note that, as with any asbestos claim, the deadline in most states runs from the date of diagnosis, and your own account of your work history is the most time-sensitive evidence in the file.

The abdominal form is less familiar, and that sometimes leaves people unsure whether the same options apply to them. They do. It's an asbestos disease, and the claim is built the same way.

We'll handle the reconstruction. There's no cost to find out what your history supports, and no fee unless we win. If you'd rather begin with the medical side, ask for the complete pathology report and the date of diagnosis, since both do double duty.

It costs nothing to find out where your family stands.